← Evidence map

ArticleFrontiers in pharmacology2023

Long-acting dolutegravir formulations prevent neurodevelopmental impairments in a mouse model.

Emma G Foster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38149054